GSA Capital Partners LLP Invests $312,000 in Orthofix Medical Inc. (NASDAQ:OFIX)

GSA Capital Partners LLP acquired a new position in Orthofix Medical Inc. (NASDAQ:OFIX) in the third quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 19,977 shares of the medical device company’s stock, valued at approximately $312,000. GSA Capital Partners LLP owned approximately 0.05% of Orthofix Medical at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of OFIX. nVerses Capital LLC bought a new position in Orthofix Medical during the 2nd quarter valued at approximately $27,000. Quest Partners LLC purchased a new position in shares of Orthofix Medical during the 2nd quarter worth approximately $64,000. Zurcher Kantonalbank Zurich Cantonalbank grew its holdings in shares of Orthofix Medical by 25.5% during the 2nd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 9,435 shares of the medical device company’s stock worth $125,000 after acquiring an additional 1,919 shares during the period. Arizona State Retirement System purchased a new position in shares of Orthofix Medical during the 2nd quarter worth approximately $139,000. Finally, XTX Topco Ltd purchased a new position in shares of Orthofix Medical during the 2nd quarter worth approximately $175,000. 89.76% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of research analysts have weighed in on OFIX shares. Roth Mkm reiterated a “buy” rating and set a $22.00 target price (up previously from $20.00) on shares of Orthofix Medical in a report on Friday, November 8th. Stifel Nicolaus upgraded Orthofix Medical from a “hold” rating to a “buy” rating and upped their target price for the stock from $18.00 to $24.00 in a report on Friday, November 8th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. According to data from MarketBeat, Orthofix Medical currently has a consensus rating of “Moderate Buy” and an average target price of $23.00.

Orthofix Medical Price Performance

Shares of Orthofix Medical stock opened at $18.91 on Friday. Orthofix Medical Inc. has a one year low of $10.28 and a one year high of $20.73. The stock’s fifty day moving average is $16.58 and its 200 day moving average is $15.61. The stock has a market cap of $722.55 million, a P/E ratio of -6.04 and a beta of 1.05. The company has a debt-to-equity ratio of 0.25, a quick ratio of 1.11 and a current ratio of 2.39.

Orthofix Medical Company Profile

Orthofix Medical Inc operates as a spine and orthopedics company in the United States, Italy, Germany, the United Kingdom, France, Brazil, and internationally. It operates through two segments, Global Spine and Global Orthopedics. The Global Spine segment manufactures and distributes bone growth stimulator devices for enhance of bone fusion, including adjunctive and noninvasive treatment of cervical and lumbar spine, as well as a therapeutic treatment for non-spine; designs, develops, and markets a portfolio of motion preservation and fixation implant products, which are used in surgical procedures of the spine; and offers biological products, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers, and tissue forms, which allow physicians to treat various spinal and orthopedic conditions.